Sign in

CIK 0001420565

  • Non-accelerated filer
  • Smaller reporting company

Rein Therapeutics, Inc.

Sign in to watch
Ticker
RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
134196017
Phone
+1 737-802-1989
Business address
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
Former names
Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale 10% owner sold 6,607 shares at an average $3.26 ($21,568)
  4. 4 Open-market sale 10% owner sold 24,671 shares at an average $3.27 ($80,710)
  5. 4 Open-market sale 10% owner sold 12,315 shares at an average $3.29 ($40,528)
  6. 3 Insider Initial Statement of Ownership
  7. 4/A Open-market sale 10% owner sold 20,315 shares at an average $4.21 ($85,473)
  8. 4 Open-market sale 10% owner sold 31,151 shares at an average $4.47 ($139,103)
  9. 3 Insider Initial Statement of Ownership
  10. 4/A Derivatives Options or other derivatives
  11. 4/A Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Exercise or conversion President and COO acquired 2,000 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy President and COO bought 225 shares at $3.37 ($758)
  17. 4 Open-market buy President and COO bought 5,076 shares at $1.97 ($9,987)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 2 of 11 · 208 filings